Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis

BACKGROUND: COPD is a highly heterogeneous disease. Potential biomarkers to identify patients with COPD who will derive the greatest benefit from inhaled corticosteroid (ICS) treatment are needed. Blood eosinophil count can serve as a predictive biomarker for the efficacy of ICS treatment. The aim o...

Descripción completa

Detalles Bibliográficos
Autor principal: Cheng, Shih-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132232/
https://www.ncbi.nlm.nih.gov/pubmed/30233168
http://dx.doi.org/10.2147/COPD.S175017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132232/
https://www.ncbi.nlm.nih.gov/pubmed/30233168
http://dx.doi.org/10.2147/COPD.S175017

Ejemplares similares